Dianthus Therapeutics (NASDAQ:DNTH) Research Coverage Started at Robert W. Baird
Robert W. Baird started coverage on shares of Dianthus Therapeutics (NASDAQ:DNTH – Free Report) in a report released on Friday morning, MarketBeat Ratings reports. The firm issued an outperform rating and a $58.00 target price on the stock. DNTH has been the subject of a number of other research reports. HC Wainwright initiated coverage on […]
More Stories
Contrasting Wetouch Technology (NASDAQ:WETH) and Siebert Financial (NASDAQ:SIEB)
Profitability This table compares Siebert Financial and Wetouch Technology’s net margins, return on equity and return on assets. Net Margins...
Mueller Water Products, Inc. (NYSE:MWA) Short Interest Down 20.8% in October
Mueller Water Products, Inc. (NYSE:MWA – Get Free Report) saw a significant decline in short interest during the month of...
NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) Short Interest Down 20.3% in October
NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO – Get Free Report) was the recipient of a large drop in short interest during the...
Mizuho Financial Group, Inc. (NYSE:MFG) Short Interest Down 21.2% in October
Mizuho Financial Group, Inc. (NYSE:MFG – Get Free Report) saw a significant decrease in short interest during the month of...
Northeast Community Bancorp, Inc. (NASDAQ:NECB) Sees Large Decline in Short Interest
Northeast Community Bancorp, Inc. (NASDAQ:NECB – Get Free Report) was the target of a significant decrease in short interest during...
Mercantile Bank Co. (NASDAQ:MBWM) Short Interest Update
Mercantile Bank Co. (NASDAQ:MBWM – Get Free Report) was the target of a significant decline in short interest during the...